← Back to ListCompanyIncheon Startup Park is the first space in Korea where the public and private sectors collaborate to nurture startups. It consists of InSta I, operated by a public institution (Incheon Technopark), and InSta II, operated by a private company (Shinhan Financial Group). Here, we introduce the representative resident companies of InSta I.
These startups have been recognized for the future value of their products and the growth potential of their companies, having been selected for Korea's highest-level startup preferential programs, and they are spreading their wings wide to leap toward becoming 'unicorn companies' — startups valued at over USD 1 billion.
RudaCure Inc. (CEO Yongho Kim), which leverages basic biomedical research to present a new paradigm in new drug development capable of achieving fundamental treatment for intractable conditions, is working on developing a dry eye disease treatment without side effects and a non-addictive pain treatment.
Focusing on the market for age-related eye diseases, the company has gained attention for developing and patenting eye drops for treating ocular conditions such as dry eye disease. ← Back to List
Who will be the future unicorn? Incheon Startup Park builds the path
2021-07-16
These startups have been recognized for the future value of their products and the growth potential of their companies, having been selected for Korea's highest-level startup preferential programs, and they are spreading their wings wide to leap toward becoming 'unicorn companies' — startups valued at over USD 1 billion.
RudaCure Inc. (CEO Yongho Kim), which leverages basic biomedical research to present a new paradigm in new drug development capable of achieving fundamental treatment for intractable conditions, is working on developing a dry eye disease treatment without side effects and a non-addictive pain treatment.
Focusing on the market for age-related eye diseases, the company has gained attention for developing and patenting eye drops for treating ocular conditions such as dry eye disease.